BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Stock buybacks
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$116,000FY2021
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $116,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCLI financial trends
BCLI RevenueBCLI Net incomeBCLI Net marginBCLI Gross profitBCLI Gross marginBCLI Operating incomeBCLI Operating marginBCLI Operating cash flowBCLI Free cash flowBCLI Capital expendituresBCLI Return on equityBCLI Dividends paidBCLI Total assetsBCLI Total liabilitiesBCLI Shareholders’ equityBCLI overview →